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AI in Healthcare:
ethics, challenges,
and implications
JuWon Park

From the Terminator to Iron Man’s JARVIS, the
media has shaped our perception of artificial
intelligence. The advent of artificial intelligence
is felt through the daily use of virtual assistants
like Apple’s Siri and Amazon’s Alexa. In addition,
there has been an increase in concerns about the
replacement of human jobs by robots and artificial intelligence as they become more advanced
and capable of more complex tasks. Especially in
medicine and healthcare, physicians have been
apprehensive about this topic as computer-assisted image analysis and deep learning continue to
advance.
The potential applications of AI in medicine have
given rise to ethical challenges because of its capacity to threaten patient preference, safety, and
privacy [17]. Current policies and ethical guidelines for AI technology in healthcare are falling
behind the progress made. The most pressing
concerns address patient privacy and confidentiality, the boundary between the roles of humans
and AI, and future education of physicians concerning changes in medicine. The lack of policy
and guidelines also gives way to other limitations
of implementing AI in hospitals. The lack of regulation for disease-diagnosing algorithms involves
liabilities in case of errors and malfunctions that
raise ethical and privacy questions not addressed
with regulations [19].
In one study, students were less likely to schedule
diagnostic stress assessments when the provider
was automated, even when the human provider
was equally accurate. The distrust of “automated”
providers, or medical AI, comes from a concern
called uniqueness neglect. Consumers believe
that machines can only operate in a standardized
way that makes them incapable of making accurate medical decisions because they are unique.
In the same study, by contrast, participants were
more likely to use a medical service when medical AI supported a human provider who made decisions [11]. This further strengthens the value of
using AI in healthcare.
People think that computer vision and interpreting medical images through algorithms can replace doctors that rely on images to diagnose and
treat patients. Research has shown that a doctor’s
bedside manner can affect healthcare outcomes
[12]. Even a patient’s relationship with their doctors and their expectations about healing, which

develops from their relationship, have shown
that social context can drive placebo responses
[23]. Soft skills like interacting with patients and
bedside manners are irreplaceable and even have
positive effects on patients.
The data-intensive scientific era has made it advantageous for physicians to become familiar
with AI analytics. Especially within the medical
field, medical AI users should be more aware that
the input data quality limitations have health implications because they affect the model accuracy
for predicting clinical disease risks and patient
outcomes [12]. Because these deep learning algorithms rely on large amounts of high-quality
medical data, patients with rare diseases cannot
be treated in this way. This would also be the case
of diseases that require expensive sophisticated,
invasive, or dangerous tests [4].
There have been further talks about using AI as
an empowerment tool for healthcare providers.
Implementing AI in medicine and healthcare is
inevitable. The promising future of AI in medicine has not gone ignored. An Accenture report
estimates that the AI health market will hit $6.6
billion by 2021, which is a $6 billion increase from
2014. As the industry grows, it will be difficult for
healthcare providers to avoid the use of AI. It will
be providers that utilize AI who will replace those
who do not.
For example, Stanford-Google digital-scribe pilot
research aims to use AI-assisted voice recognition to enter data into a patient’s electronic health
record systems while simultaneously patients are
in the room [2]. This technology aims to reduce
the time physicians spend manually entering
data, which has shown to take up one-sixth of an
average physician’s working hours [31]. In fact, a
Mayo Clinic study has linked EHRs with physician
burnout [22]. Physicians that utilize this technology will replace ones that do not; they can take
advantage of this technology to better support
patients.
The hype about AI has given rise to concerns that
have yet to be addressed for further implementation. As more research and advancements are
made, what can we say about the future of AI in
medicine in the next 10 years?
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Possible
Treatments of
Respiratory Diseases in Infants
Erin Yoo
Respiratory distress syndrome (RDS) is a respiratory disorder
which frequently appears in preterm babies, especially those
born six or more weeks early. This condition appears when
low levels of surfactant are present in premature lungs (some
full-term babies may also get RDS because of genetic factors
that affect the production of surfactant) [34]. Surfactant is a
compound in the lungs that prevents them from collapsing.
They are specifically located in tissues around the alveoli to
prevent the alveoli from sticking to one another. If the alveoli in the lungs were to stick together, it would block oxygen
from entering the baby, which can lead to other complications. Symptoms of RDS can include breathing problems such
as quick, shallow breathing, chest sharply pulling inwards
during inhalation, grunting, nostrils flaring, and apnea (pauses between breaths that lasts for a few seconds). Infants diagnosed with RDS are moved to the neonatal intensive care unit
(NICU) of a hospital [34].
Though most infants with RDS survive, they require extra
medical care and treatment. Three main treatments are used
to counter RDS: surfactant replacement therapy; breathing
support; and oxygen therapy. Each therapy has its own benefits and drawbacks. In surfactant replacement therapy, surfactant is supplied to the baby through a tube that is attached
to a ventilator or an NCPAP (nasal continuous positive airway
pressure machine) to provide breathing support. NCPAPs
have recently become more popular than ventilators because
of their gentle push of air through the nostrils. This is used
until the baby can produce sufficient levels of surfactant on its
own. The breathing support method uses the breathing machines mentioned above (ventilators and NCPAPs). Because
RDS can cause other disorders such as a lung hemorrhage,
blindness, and other eye problems, treatment can also entail
treating related conditions [35]. Although these treatments can
be life-saving, they can also cause more respiratory damage
such as chronic breathing problems, asthma, brain damage,
and bronchopulmonary dysplasia (BPD results when preterm
infants with RDS are still suffering from it by their original
due date). There is no long-term protection from BPD currently. Thus a safer treatment for respiratory disorders would be
extremely useful and valuable for premature infants.
One such potential treatment is curcumin. Curcumin is a substance found in turmeric, a spice. Turmeric is largely used in
8

Indian cooking such as curry, and also in many
Asian cultures as a medicine. Studies and modern research show how curcumin could be
used to help prevent and treat BPD, other respiratory disorders, and even cancer. According to research by the Department of Biology
from Texas Southern University, curcumin has
been shown to suppress the development and
spread of tumors through experiments conducted on rodents [24]. In addition, research
conducted by the Institute of Biosciences and
Technology show that curcumin can prevent
airways from swelling, or inflaming, (as in
BPD) in mice [13]. Similarly, an experiment
done by the American Journal of Physiology
concluded that curcumin could protect developing lungs from bronchopulmonary dysplasia (BPD) [18].

that two main anthocyanins (delphinidin and
cyanidin) in the berries were able to decrease
levels of IL-8 production in cells treated with
cigarette smoke extract [9]. Anthocyanins are
pigments known to have antioxidant effects
and are found in red, purple, and blue colored foods like blueberries, raspberries, and
grumichama. Moreover, chemokine interleukin-8 (IL-8), is a cell that takes part in inflammation during the immune response. IL-8
proteins also cause the release of other inflammatory molecules to lung tissue, resulting in more damage to the lungs. Because the
anthocyanins were able to lower the amount
of IL-8 proteins in cells treated with cigarette
smoke extract, grumixamas could be used in
anti-inflammatory treatment for respiratory
disorders as well. Consequently, infants living in a household where cigarette smoke is
prevalent, though not ideal, may soon have
an option to treat their lungs from cigarette
smoke.

Fibroblasts, specifically lipofibroblasts, which
can differentiate into myofibroblasts, are cells
in connective tissue that are located in the
lungs. Lipofibroblasts take part in preventing
inflammatory injuries in the lungs, whereas
myofibroblasts are commonly found in tissue with chronic lung diseases, like BPD. This
transformation from “lipo” to “myo” is caused
by the peroxisome proliferator-activated receptor gamma molecules (PPAR-γ) [18]. Curcumin has been found to affect those gamma
molecules by blocking the transformation of
“lipo” to “myo”, showing curcumin’s potential
to reduce and prevent swelling in the lungs
[18]. This experiment was done by treating
mice with curcumin via injections and comparing the results to mice who were not injected. Experimental mice were placed in containers with more concentrated oxygen for 5 days
to simulate hyperoxia, while control mice were
kept in containers in regular conditions. It was
discovered that curcumin prevented a decrease in alveoli numbers, increase in alveoli
thickness (thinner alveoli makes gas exchange
and breathing easier), and inflammation of
the airways [18]. All these studies and research
show that curcumin could be a very valuable
tool in treating BPD, respiratory, and other inflammatory disorders.

So how could these possible treatments and
preventions help our youngest and most anatomically different people—infants? Current
treatments for common respiratory disorders
among infants are not completely practical,
as they can cause more damage to developing lungs. Thus, the other options reviewed
above, curcumin and grumichama berries,
may be a safer option for the young patients.
Applications could include simple vaccine,
pills, or other forms of oral medications. On
the other hand, patients could use these foods
as supplements, while also utilizing standard
treatments. This could allow patients to use
multiple treatment options while getting the
same results as the more risky and traditional
solutions.
In the end, it seems as if all the needed solutions are already readily available to us,
whether in man-made innovations like inhalers and ventilators, or in nature like turmeric
and berries. Because disorders like asthma
and BPD are so diverse, it’s advantageous that
there are many tools available. In the event
that conventional treatments and medicines
may not work or may not be accessible for a
specific patient, it is valuable to keep up-todate with research on the respiratory system
and new possible treatment methods.

Another food, grumichama berries or Brazil
cherries, have been studied as a possible tool
for therapeutic treatment in respiratory disorders. Grumichama originates in Brazil, and is
similar to a cherry (hence “Brazil cherries”); it’s
just a little smaller. An experiment conducted
by the Department of Biological Sciences from
Lehman College and Graduate Center found
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Black Holes
Suppress the
Growth of Dwarf
Galaxies

Phyllis Shen
Black holes influence the formation of stars
within galaxies [25]. Galaxies are clusters of
stars held together by gravity, and the size of a
galaxy is determined by the distribution of its
stars. Dwarf galaxies are the most common type
of galaxies in the universe, often orbiting larger
galaxies and containing up to a few billion stars.
For comparison, the Milky Way galaxy contains
between 200-400 billion stars. In a recent recalculation of the mass of the Milky Way, scientists
observed that black holes within the center of
galaxies influence the way globular clusters
around the galaxies form and travel around the
center of the galaxy [20].
Black holes and dwarf planets allow scientists
to study the evolution patterns of galaxies. Researchers from the University of California,
Riverside have used telescopes in Hawaii to
observe winds around various black holes and
have found that black holes create winds that
hinder the formation and development of stars,
thus preventing the growth of small galaxies.
These winds were observed to be stronger than
the researchers had initially anticipated, having a drastic effect on the expansion of dwarf
galaxies. The research done at the university
focused on six dwarf galaxies, each with black
holes that created gusts of wind moving at high
velocities and containing ionized gas particles.
These winds are created when particles in outer
space come into contact with black holes. This
contact generates high heat, due to friction and
the strong gravitation of black holes. The heat
causes massive amounts of energy to be generated to push gas particles out of the black hole.
While wind produced by black holes can compress surrounding gas particles to form stars,
the gas released from these black holes in dwarf
galaxies does not compress surrounding particles because the gas itself comes from the black
hole and is unable to form stars. Therefore, the
presence and strength of the black holes within
a galaxy are what determines the size of the galaxy by regulating the formation of stars. These
discoveries may have further implications beyond the basic observation of star formations;
they may potentially allow scientists to measure other properties of black holes and different-sized galaxies relative to their effects on
each other [1].
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A supermassive black hole found at the center of a
dwarf galaxy in 2014, as captured by the SINFONIA
instrument from the European Southern Observatory's Very Large Telescope in Chile [5]. This was the
smallest galaxy in which this type of black hole was
known to exist, which opened the possibility of finding other supermassive black holes at the centers of
other dwarf galaxies.

DARPA Funded
Gene Modulation,
the New Genetic
Medicine?
Ashley Koca
The Defense Advanced Research Projects Agency, DARPA,
is an organization out of the United States Department of Defense whose primary purpose is to progress the development
of military technologies, first inspired and motivated by the Soviet threat “Sputnik.” Within this agency resides a program, the
PReemptive Expression of Protective Alleles and Response Elements (PREPARE), designed to counteract four major categories
of human ailments: opioid overdose, organophosphate poisoning, exposure to gamma irradiation, and influenza infection [6].
PREPARE strives to design new methods of identification and
development of medical countermeasures to promote genes
that assist in protection against the ailments aforementioned—
but with one major rule: the medical countermeasures must affect the genome without permanent alteration [7].
DARPA, most recently, has employed five teams to address influenza immunity and radiation protection within the gut. Each
team strives to reach the end goal of producing at minimum one
product to be reviewed by the U.S. Food and Drug Administration. Representing Columbia University, Dr. Harris Wang and
members of the Wang lab comprise one team of DARPA’s PREPARE initiative, pursuing a 9.5 million dollar study attempting
to reduce the impact of radiation on the gut and blood through
preventative therapy [28].
Although the focus on the blood and gut is seemingly oddly specific, the reasoning boils down to the fact that, in Homo Sapiens,
the ionizing effects of radiation predominantly impact the stem
cells housed in both those regions [21]. The risk of radiation impacting the gut/bloodstream not only would impact soldiers, the
main interest of DARPA, but would affect those using radiotherapy as a cancer treatment option—thus expanding the benefits
of this technology outside the realm of warfare.
Current technologies attempting to combat the issue, unfortunately, fall short. Common practices now work to regenerate
blood cells, but only if delivered immediately after exposure to
radiation. Prophylactic treatments have yet to be a reality, but,
with the work of Dr. Wang and colleagues, they will hopefully
soon become commonplace.
The Wang lab plans to design a programmable gene modulator
capable of oral introduction. Gene modulators are tools that alter the expression of genes. These tools are designer molecules
like triplex-forming molecules, synthetic polyamides, and zinc
finger proteins [29]. Several mechanisms exist when utilizing
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these different molecules. The triplex-forming
molecules bind to the DNA helix and form a triple helical structure, allowing for a reduction
in the gene’s transcription. Synthetic polyamides inhibit transcription with sequence-specific minor groove DNA recognition. In that, they
are a small collection of molecules that hydrogen bond to the minor groove of DNA through
the specific recognition of base pairs. Zinc-finger proteins bind instead to the major grooves
of DNA. The modulation of zinc-finger proteins
is more complicated, in that it can perform in a
multitude of ways. In the case that the sequence
the protein is targeting is an exon, transcription
will be obscured. Another example of the range
of zinc-finger motifs would be if the sequence is
a methylase domain, in which case zinc-finger
binding will only increase the methylation of the
surrounding sequence.

equal potential for harm as well as good by
these gene devices must be taken into consideration when developing new tech.
The support of organizations such as DARPA is
crucial to the progression of science as it provides researchers with a plethora of financial
opportunities and the support needed to conduct their science. Additionally, the interest of
the Department of Defense is monumental in
and of itself as it signifies the relevance of such
research outside of the niche scientific community—the research has valuable, real-world
applications that transcend the borders of pure
academia. The continued support of these
agencies provides hope to the scientific community, the US’ need for the advancement of
science has not faltered since the origins of
DARPA—the Sputnik scare has yet to be forgotten.

The lab anticipates that the modulator will take
hold in both the intestines and the liver. After
which, the modulator should then induce the
protection and regeneration of cells through regulating gene expression—which, in turn, changes protein production. This then causes the liver
cells to prompt the regeneration of red blood
cells within the bone marrow. Risk of gastrointestinal injury due to radiation has been suggested by scientists to be linked to genotypic variations, hence the importance of gene modulation
as a treatment option.

The modulator should
then induce the protection and regeneration
of cells.
When contemplating systems of genetic alteration, those in control must consider the ethics and potential implications of their actions.
The genetic manipulation of any organism risks
complications that could permanently alter the
environment or the entire population of the organism that the method of manipulation was designed to affect. Although this modulator is not
designed to change the genes themselves merely
their expression, certain alterations or increases
in frequencies of expression could spell doom
for an organism. Alternatively described as an
“extinction tool,” gene drives and other instruments of gene alteration have been recognized
for their potential benefits to society as well as
their potential for extreme consequences. The
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Biomarkers of Chronic Pain:
Precision Measurement and
Application
Hiteshi Patel

According to the CDC, 1 in 5 patients
suffer from some type of chronic pain.
Thus, chronic pain is a condition many
patients combat on a daily basis, given
that there is no general cure for the pain
[26]. While there are coping options
that patients can pursue in an attempt
to alleviate the pain, it will never fully
go away. Hence, researchers are now
attempting to understand how chronic
pain affects the human body at a cellular level in order to eventually create a
lasting solution.

ery process: prioritization, validation,
and testing. In the prioritization stage,
a powerful longitudinal design within
patients suffering from various psychological disorders was utilized to
prioritize candidate biomarkers and
characterize the relationship between
perceived and biological pain. Next,
the top biomarkers were validated in
patients actually diagnosed with pain
disorders in an independent subject
cohort. Following various clinical testing, the biological pathways of each
biomarker were identified along with
correlations with existing drugs. From
this, it was found that “GNG7, CNTN1,
LY9, CCDC144B, and GBP1” [15] were
the main biomarkers involved with

This is done by identifying biomarkers in various biological features such
as, most recently, in blood. The identification of common biomarkers was
completed through a stepwise discov14

pain. Furthermore, these biomarkers can
now be used as key components of assays
in pain drug discovery.
As one of the main groups who suffer
from chronic pain is cancer patients, researchers are focusing on the biomarkers
specific to cancer patients as pain indicators. Since many cancers are based
on genetic variants, genetic biomarkers
were the focus of a study that explored
pain pathways in cancer patients. This
study found that single nucleotide polymorphisms (SNPs) are a common stable
biomarkers in pain risk. As they change
the genetic sequence of a gene’s protein,
they are also likely to interact with cancers and affect their pain levels.
Hence, this opens a future for
further investigation and potential drug development.

This opens
a future for
further investigation
and potential drug
development.

In an attempt to utilize this information for good, a company
based in Indianapolis called
MindX Sciences strives to quantify pain levels through digital
qualitative patient interviews
and blood tests [26]. This is especially important since it is
difficult for physicians to analyze pain levels in patients who
suffer from diseases that prevent them from accurately conveying their pain. This company will use
the research of indicators and hopefully
apply it to accurately gauge pain levels.
Overall, pain research is one of the main
focuses for bioresearchers today, given
the difficulty physicians have in measuring it. It is extremely likely more advances
in pain research will be seen in the future.
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How
Regenerative
Medicine is
Leading to
Discoveries

16

Osayenmwen Omozusi

Regenerative medicine is a promising field
working to restore the structure and function of damaged tissues and organs. Additional ly, regenerative medicine is working
on finding solutions for permanently damaged tissues. Researchers are now discovering that cartilage in human joints could
perhaps repair itself in a manner similar
to animals such as axolotl, zebrafish, and
bichir also exhibit. This possibility of cartilage regeneration could lead to a possible
cure in arthritis, which is an inflammation
of the joints [30]. The study’s focus was cartilage regeneration in the hip, knee, and ankle regions [10].
Young proteins play an important role in the
recovery and repair of tissues in the muscles, skin, organs, blood, hair, and nails. In
the study, they found that young proteins
help cartilage regeneration. They determined that the hip had the lowest amount
of young proteins, while the knee had
slightly more proteins than the hip, and the
ankle had had the highest amount of young
protein [10]. The researchers devised a way
to determine the age of proteins to discover
the mechanisms behind these findings.

Professor Kraus, a professor at Duke
University, and colleagues found the
age of proteins using internal molecular clocks integral to amino acids,
which convert one form to another
with predictable regularity. They discovered that newly created proteins in
tissue have few or no amino acid conversions, but as proteins become older,
they have many amino acid conversions [14]. Similarly, the age of cartilage
largely depended on where it resided in
the body. Cartilage in ankles is young,
while it is middle-aged in the knee and
old in the hips. The younger the proteins are, the more efficient they are at
healing [30].
Scientists also discovered that microRNA regulates the process of how long
an area will heal. MicroRNAs are more
active in animals that are known for
limb, fin or tail repair, including salamanders, zebrafish, African freshwater fish and lizards. These microRNAs
are also found in humans — an evolutionary artifact that provides the capability in humans for joint tissue repair
[10]. As in animals, microRNA activity
varies significantly by its location: it is
highest in ankles compared to knees
and hips and higher in the top layer of
cartilage compared to deeper layers of
cartilage. Scientists like Dr. Ming-Feng
Hsueh who research arthritis, are calling this the “inner salamander capacity” because it displays how possible
cartilage regulation can take place [14].
The study of microRNA will advance
medicines that could prevent, slow
or reverse arthritis. Kraus says she is
“very hopeful” that the findings could
lead to therapies. One day, they also
might discover how to regenerate part
or all of a human limb. Potentially, she
suggests, microRNAs could be “Injected directly into a joint to boost repair
to prevent osteoarthritis after a joint
injury or even slow or reverse osteoarthritis once it has developed.”
Although we still have a long way to go
to explain why humans cannot regenerate, this study provides compelling
evidence that there are many similar-

ities between human and salamander
limbs. As stated by Professor Kraus, “If
we can figure out what regulators we
are missing compared with salamanders, we might even be able to add the
missing components back and develop
a way someday to regenerate part or all
of an injured human limb.” This is only
the beginning of regenerative medicine [30]. In the future, it could be applied to other tissues, not just cartilage.

An evolutionary artifact that provides the
capability in humans
for joint tissue repair.

Interview: On the
New Rhetoric and
Communication Course
caitlyn castillo interviews mr. dean, dr. randall, and students
Living and learning in a mathematics and science
academy, we’re surrounded by a myriad of STEM.
From the original theories introduced thousands of
years ago to the new innovations that come to life
each day, we’re constantly gathering new information. As we ponder concepts and ideas, it’s interesting to learn about how they are presented to us.
Mr. Dean and Dr. Randall tackle this field through
the new, senior-only english elective Rhetoric and
Communication: Science. The following interview
has been edited for clarity, but the content has
been approved by Mr. Dean, Dr. Randall, and the
students interviewed.

such as how scientists communicate with each
other, and then how that science gets communicated to real participants in the world. We wanted
to think about the different people who have buyins into scientific information. So, our plan was to
structure our class around different communication experiences that relate to a similar topic. Dr.
Randall has a specific focus in science, she has her
background. We wanted to keep it close to what
we know. When we were designing it, we wanted
to imagine the flexibility if it were a different set
of teachers. So, if wasn’t Dr. Randall and me, students could conceive the class in different ways.
You could have a physics teacher step into the
classroom and do something completely different.
Part of the benefit of it now is that Dr. Randall has
experience in the fields that we’re learning about.
I have my own experiences in communication as
well. With a literary background, I’ve also taken
courses in Technology Communication and Visu-

What inspired you to start this class?
Mr. Dean: It was sort of as a joke. We were learning
about intersession at the time, and we joked around
that we could do something about zombies. People
laughed a bit, but then Dr. Randall said we could
do a lot with that. It could be humanities-oriented, while also having a science base. This meant
looking at the cross appeal, such as the metaphor
of zombies, how diseases behave like zombies, and
why do we tell stories with zombies in them. We
were able to do this intersession, and the year after
that we did another one about the story of a germ.
After doing these intersessions, we were looking to
do this in a more authentic experience.

We tried to think
of information as
a life cycle.

How did you get started on planning it?
Mr. Dean: We went into it thinking of just coming
up with a class. We didn’t worry about the logistics
of it, but we just wrote what we would want to do
with it. Then, we threw it to the school and said
‘This is our plan, how do we make it happen?’
Dr. Randall: We tried to plan it in a way where, if
there’s interest, different science and humanities
faculty could pop in. This year, our theme is neglected tropical diseases and rare genetic diseases,
because they’re related to my biology background.
But, it could have any theme depending on who’s
teaching.

al Rhetoric, so I’ve got some tools that I can bring
to the classroom as well. I can imagine if you had
different teachers, they’re going to have their own
expertise and experience, too.
Dr. Randall: We wanted to give students an opportunity to have a class that is as rigorous in science
as it is english. We wanted to give them a chance to
build a portfolio of work, and the best way to learn
how to communicate is to practice doing it. Our
goal was to allow students to have a personalized
version of the project that we used to do in Biology
Seminar (a former literature review class) — within certain guidelines, you’re able to pick a topic
and work with it throughout the semester.

What was your vision for the class?
Mr. Dean: We tried to think of information as a
life cycle. Where does it start? Who creates knowledge in science? How is it channeled? We’re very
focused on professional communication channels

From what you’ve seen so far, is there anything that
you would have done differently?
Dean: We question if we can get more experimen-
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tal with it. What if we put together a board game?
Or did an assignment on interpretive dance? But,
the problem with that, is that we first wanted to
give ourselves a basis. Additionally, those are very
hard ideas to evaluate. Thinking about what we’re
getting out of it is very difficult. For example, how
do we look back on an assignment and think ‘Yes,
that was worth our time.’ But, I think there’s science communication out there that’s not traditional. Like memes, there’s always other things
out there. I would need a lot more research to really grasp the field. Ultimately, when we get a better handle on it, I wouldn’t mind experimenting.
That’s where I want the class to go.
Dr. Randall: Just yesterday, we had a conversation
about how much creativity we allow or having
some other less formal opportunities to present. If
we were to do it again, we might have an expanded improv day, where we’d ask questions such as
“If you were to do outreach to young people, could
you design a lab?” Next year we hope to allow some
time for more creative projects.

ented students that have input into their learning
process.
Dr. Randall: Seeing the work that students put together. I’ve been really impressed. This is what we
we’re hoping for. Seeing students work hard to understand the science and put things together has
been very rewarding and fun. Hopefully they’ve
found it fun, too.
The structure of the class consists of students working
in groups of 3-5 people putting together projects on a
specific neglected tropical disease or rare genetic disease. Here are a couple of questions and answers from
some seniors currently taking the class. The names of
the students are redacted for privacy, but they have
read over their responses to ensure that their opinion
is true.
What were you expecting when you took this class?
Student 1: I was expecting pretty much what I got.
There’s a lot more science than English which is
fine by me since those have consistently been my
best and worst subjects respectively.
Student 2: I’m not really sure if I’m gonna be honest, I just knew that I wasn’t that good at scientific
writing and the class focused it on that and I knew
it wouldn’t be easy—given that both teachers are
demanding and the class itself would be challenging—but it interested it me more than the other
English courses.

What do you hope students will gain from this class?
Mr. Dean: Real working experience. I want you
guys to feel like you could walk into an interview
and be able to discuss real experience in science
communication. Also, that you feel that the work
you do is valuable to your time. This class is less
about us teaching you from on-high, and more
about you taking the tools and skills that we learn,
and applying them to real situations. Because,
that’s what I think rhetoric is all about.

What are your favorite parts about this class?
Student 1: I enjoy the collaborative nature of
the class and how we always work with the same
groups and have larger projects over longer periods of time instead of constant work.
Student 2: I feel like I learned more than I thought
I would, and I pay more attention to scientific writing and notice details that I would’ve had before. I
am more attentive to scientific writing now.

What are your biggest struggles with this class?
Mr. Dean: I’ve never co-taught before. With most
of the classes that I teach, I would consider myself an expert in those topics. But, in this case, I
would not consider myself an expert in science.
For me, that’s exciting, but also scary. I have to really collaborate. Dr. Randall and I would meet almost weekly; we looked at work together, debated
ideas, had disagreements, and negotiated them.
We thought about what we could do together, and
what we’re individually good at. So, as much as this
is a learning experience for you guys, I’ve also professionally benefitted from the class. We’re learning from each other. It’s forced me to grow and
take risks, and I think that’s fun.

What are you least favorite parts about this class?
Student 1: I don’t like the high expectations that
the teachers have of how quickly we can learn certain topics, especially those from presentations
by other students. I think assessments should be
more about what we learn about scientific communication and less about actual science.
Student 2: I think some of the assignments are unnecessary and are just assignments created to pass
time.

What are your favorite parts about this class?
Mr. Dean: Seeing what you guys have produced
each time. The fact that we can get into that classroom and just talk about something. Almost everybody in that room is throwing out great ideas and
addressing ideas that I haven’t thought of. It makes
me think “This is what IMSA is.” Working with tal-
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Mathematical
Epidemiology: Past
Findings and Future
Possibilities
Madhav Parthasarathy

Have you ever wondered how and why diseases
spread? Well, the answer to that is Mathematical
Epidemiology! Mathematical Epidemiology is the
mathematical modeling of diseases to determine
the rate at which people become infected with
diseases. The study of infectious disease data began with the work of John Graunt in his 1662 book
“Natural and Political Observations made upon
the Bills of Mortality,” which lists weekly records
of numbers and causes of death in the London
parishes. These records began in 1592 and were
kept continuously since 1603 [3]. Graunt analyzed
the different causes of death and created a method
of estimating the risks of dying from different diseases. This was the first approach used to analyze
data to determine the various risks of the disease.
Now, what I just talked about was the first study
of infectious disease data, but the first model in
mathematical epidemiology was the work of Daniel Bernoulli on inoculation against smallpox. Variolation was introduced as a method to produce
immunity against smallpox, with the negligible,
mostly, risk of possible death. There was debate
held on whether variolation was actually beneficial, and Bernoulli was told to lead the study to
answer this controversial question. The approach
Bernoulli used was to calculate the increase in
life expectancy if smallpox were to be eliminated as one of the causes of death. This approach
led to the publication of a complete exposition in
1766. These findings discussed were from many
years in the past, while one of the main findings
in mathematical epidemiology was the Kermack
and McKendrick model in 1927 [3]:

Here, x(t) is the number of people who are susceptible to the disease itself, y(t) is the number of
infectious individuals, and z(t) is the number of
recovered individuals.
There is a clear history of Mathematical Epidemiology that has served as a progression for epidemiologists to be able to use. However, now the
challenge for epidemiological modeling would
be to determine which situations would allow for
slower exponential growth. This is an important
direction that epidemic modeling must take, and
suggestions to work past this challenge include
metapopulation models with spatial structures
that discuss population dynamics, such as contact rates, etc. Another direction that would be
interesting for epidemic modeling to take would
be researching contact rates decreasing in time
because of behavioral changes within individuals
in response to diseases entering the body. Contact rates are extremely important to determine
whether someone will become infected or not.
These are just a few of the future implications of
Epidemic modeling and, I hope that all of you are
as excited as I am, to see what’s in stock for the
future of this unsaturated topic that is Mathematical Epidemiology.
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The ‘Quantum Zeno
Effect,’ Explained
Alex Zhang
at all. In fact, everytime he glances at the loading icon, it seems like nothing changed! That’s
because, according to the quantum Zeno effect,
nothing—or at least very little—did change. By
measuring the system frequently enough at specific intervals, Zeno was able to arrest his video’s
time evolution (that’s assuming that his video is actually a particle abiding to quantum laws), keeping
the video at its initial conditions. Put into simple
terms, the quantum Zeno effect describes how a
quantum system can be “frozen” by measuring it
frequently enough [8],[27].

If we look at it often enough, it freezes.

Greek philosopher Zeno of Elea once had an interesting thought (as philosophers do): if an arrow in
flight is examined at an instant in time, the arrow
appears to be motionless. However, if the arrow is
motionless at every instant in time, and time is entirely composed of instants, then the idea of “motion” is complete bogus. This posed an interesting
mathematical problem.
Thankfully, “motion” was later un-bogused with
the power of calculus. An intuitive refutation of
Zeno’s paradox was provided by Aristotle, who noted that "time is not composed of indivisible nows
any more than any other magnitude is composed
of indivisibles.” That is, instantaneous moments in
time do not exist because it is impossible to complete a task (such as firing an arrow from one point
to another) with infinite steps. Bertrand Russell
further criticized Zeno’s model of motion, arguing
that, while it is true that an arrow cannot be “in
motion” at an infinitely small duration of time, all
motion requires is for the arrow to be at a point at
one time, another point at another time, and at the
appropriate points during the intervening time.
Zeno’s paradox may not be successful in dismantling the foundations of motion, but Zeno may
have been pleased to know that his ideas helped
to name an effect observed in the quantum realm.
To preface this, it’s important to acknowledge that
slapping the word “quantum” in front of a disproved paradox doesn’t necessarily make it any
more sensible, but the quantum Zeno effect—a
feature of quantum systems with an idea similar
to Zeno’s arrow paradox—is a very real and observable phenomenon [16].

A better metaphor to explain this phenomenon is
Schrodinger’s cat. Schrodinger’s famous thought
experiment hypothesized that a cat locked in a box
with a 50% of dying (usually due to a radioactive
atom) will be half-dead and half-alive, a victim of
the duality of conditions that exist within quantum
physics. What’s curious is that the quantum Zeno
effect can actually ensure that the cat always lives.
Assume the fate of the cat relies on a radioactive
atom which has a 50% chance of decaying and triggering the destruction of a poison vial. Plotting the
probability that the survivability of the cat over an
x-value of time, a negatively sloped graph arises.
This—while tragic—is to be expected; a greater
span of time leads to a higher probability that the
atom has decayed, and thus, a lower survivability
of the cat. However, if the atom is “observed” over
the course of its decay, a more lively graph takes
form [16]:

To put the quantum Zeno effect into understandable (yet nowhere near accurate) terms, take a
common example: waiting for something to load.
Suppose Zeno wanted to watch a YouTube video,
but it was taking a long time to load and he was
growing impatient. Then an idea struck him: if he
closed his eyes while waiting for the video to load,
periodically opening them to check on the progress, he might make it seem to speed up! He does
this, measuring the state of the video frequently.
However, he finds that his video—which usually
finishes loading after a short while—doesn’t load

The “bounces” in the graph correspond with the
times at which the system is measured, while the
dashed line depicts the survivability of the cat
without measurements.
Everytime the system is measured, and the atom
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still hasn’t decayed (in other words, it’s still in its
initial conditions), it’s as if nothing happened at
all. As a result, the system “resets” in a sense, collapsing the system back into its initial state, and
the process begins again. So, Schrodinger’s cat
lives on, and Zeno’s quantum YouTube video loads
in an endless spiral. As strange as it may seem,
the quantum Zeno effect has been experimentally
proven in the real world. Researchers from Cornell found ways to use the quantum Zeno effect
to freeze the tunneling of atoms—a phenomenon
that usually occurs when atoms are exposed to
extremely cold temperatures [27]. Instead of “tunneling” place to place as a result of having nearly
0 velocity, the atoms exhibited reduced tunneling
when measured.
Thankfully, the quantum Zeno effect isn’t only
understood under the context of “magic.” The active action of measuring—that is, in the Cornell
researcher’s case, shining an imaging laser on
atoms—served as an outside force, disrupting the
sensitive balance of quantum systems. This caused
the reduction of tunneling. Further, as the Cornell
researchers discovered, when measurements by
the imaging laser became brighter and/or more
frequent, the tunneling was dramatically reduced.
Paradoxically, the act of measuring itself can disturb the system meant to be measured, however
miniscule the effect may seem.
It’s evident that the quantum Zeno effect isn’t yet
readily applicable for everyday life. It may be a
long time until this phenomenon, like many other quantum phenomena, is fully understood and
ready to be taught in high school classrooms. Plus,
“understanding” requires acknowledging that
even today’s most advanced measurement instruments are inherently inaccurate on the quantum
level, allowing humans only a distorted view of
the quantum world through the lens of explorers
shining spotlights on shy particles suffering from
stage-fright. Even so, it’s valuable to take a look at
what really is reality and explore the stranger parts
of it. After all, that’s what Zeno of Elea did when
he took an aspect of reality—motion—and thought
about it for a little while, even if his work is unfounded today. Quantum physics is still a relatively
new and unexplored realm of physics, and it’s up
to the thinkers of today to un-bogus it.
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